Menu
GeneBe

rs373824622

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_004448.4(ERBB2):c.383C>A(p.Pro128His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P128A) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

ERBB2
NM_004448.4 missense

Scores

1
12

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.522
Variant links:
Genes affected
ERBB2 (HGNC:3430): (erb-b2 receptor tyrosine kinase 2) This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, ERBB2
BP4
Computational evidence support a benign effect (MetaRNN=0.25868836).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ERBB2NM_004448.4 linkuse as main transcriptc.383C>A p.Pro128His missense_variant 3/27 ENST00000269571.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ERBB2ENST00000269571.10 linkuse as main transcriptc.383C>A p.Pro128His missense_variant 3/271 NM_004448.4 P1P04626-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Uncertain
0.056
T
BayesDel_noAF
Benign
-0.16
Cadd
Benign
17
Dann
Benign
0.89
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.51
D
M_CAP
Benign
0.084
D
MetaRNN
Benign
0.26
T;T;T;T;T;T;T
MetaSVM
Benign
-0.42
T
MutationTaster
Benign
1.0
D;N;N;N;N;N;N;N;N
PrimateAI
Benign
0.30
T
Sift4G
Benign
0.17
T;T;T;T;T;T;D
Polyphen
0.71, 0.40, 0.30
.;P;.;B;.;B;.
Vest4
0.24
MutPred
0.43
.;.;.;.;Gain of catalytic residue at P128 (P = 0.0503);Gain of catalytic residue at P128 (P = 0.0503);.;
MVP
0.74
MPC
0.73
ClinPred
0.33
T
GERP RS
4.8
Varity_R
0.076
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-37864731; API